MDBHMEDIUM SIGNALFINANCIAL10-K

MDBH experienced a notable cash decline and increased liabilities while improving operating cash flow performance, amid strategic changes following the deconsolidation of eXoZymes due to dilution from its IPO.

The company's cash position declined meaningfully to $13.2M from $20.4M, while total liabilities increased 66.1% to $3.2M, suggesting either increased operational needs or strategic investments. However, the improvement in operating cash flow from -$9.0M to -$5.7M indicates better operational efficiency despite the overall balance sheet contraction.

Comparing 2026-03-31 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

MDBH's financial profile shows mixed signals with cash and equivalents declining 35.3% to $13.2M and total liabilities growing 66.1% to $3.2M, contributing to an 11.4% reduction in total assets to $63.7M. Stockholders' equity decreased 13.5% to $60.7M, reflecting the overall balance sheet contraction. Despite these reductions, operating cash flow improved meaningfully from -$9.0M to -$5.7M, suggesting better operational management even as the company navigates strategic transitions including the deconsolidation of eXoZymes following its IPO.

FINANCIAL STATEMENT CHANGES
Total Liabilities
Balance Sheet
+66.1%
$1.9M$3.2M

Liabilities grew 66.1% — significant increase in debt or obligations, assess impact on financial flexibility.

Operating Cash Flow
Cash Flow
+37.1%
-$9.0M-$5.7M

Operating cash flow surged 37.1% — exceptional cash generation, highest quality earnings signal.

Cash & Equivalents
Balance Sheet
-35.3%
$20.4M$13.2M

Cash declined 35.3% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Stockholders Equity
Balance Sheet
-13.5%
$70.2M$60.7M

Equity decreased 13.5% — buybacks or losses reducing book value, monitor solvency ratios.

Total Assets
Balance Sheet
-11.4%
$72.0M$63.7M

Total assets contracted 11.4% — asset sales, write-downs, or balance sheet optimization underway.

LANGUAGE CHANGES
NEW — 2026-03-31
PRIOR — 2025-03-31
ADDED
The value of the Class A Common Shares on June 30, 2025, was $ 22,178,831 , the last business day of the registrant s most recently completed second fiscal quarter.
These above factors should not be construed as exhaustive and should be read with the other cautionary statements in this annual report.
One of the companies in our group, Public Ventures, LLC ( Public Ventures ), which operates under the D/B/A of MDB Capital, operates as a growth catalyst, focusing on community-driven micro and small-cap financings and is a self-clearing broker dealer.
At the pinnacle of the pipeline, as of the date of filing this Annual Report on Form 10-K, two Big Idea Companies are currently in active negotiations, marking the final step before potential partnership or investment.
We believe, most importantly, that one gauge of the partner company success is that the partner company will successfully foster community, where community members who seek to create value at the companies, in connection with our self-clearing broker-dealer, Public Ventures.
MDB was one of the founders of the company, provided an initial funding of $5 million and a subsequent funding of $0.75 million and provided executive management and several board members.
A traditional perceived shortcoming of the public markets is that they attract investors focused on the short-term markets.
We used a portion of our capital to identify and find partner companies.
MDB Shareholders Under the MDB model, MDB shareholders can buy or sell their shares in the holding company in the open market at any time.
The Company s Broker-Dealer subsidiary is excluded from the Investment Company Act of 1940, and therefore all securities held by the Broker-Dealer are excluded from the asset calculation.
REMOVED
The value of the Class A Common Shares on June 28, 2024, was $ 32,131,327 , the last business day of the registrant s most recently completed second fiscal quarter.
We also call attention to the changes in the financial statements as a result of the deconsolidation of eXoZymes Inc, (formerly Invizyne Technologies Inc.) due to the sale of common stock in an initial public offering consummated on November 14, 2024, which diluted the holdings of MDB Capital Holdings, LLC to a minority ownership of approximately 47% from a majority ownership of approximately 60%.
One of the companies in our group, Public Ventures, LLC ( Public Ventures ), which operates under the D/B/A of MDB Capital, operates as a growth catalyst, focusing on community-driven micro and small-cap financings.
At the pinnacle of the pipeline, as of the date of this report, two Big Idea Companies are currently in active negotiations, marking the final step before potential partnership or investment.
We believe, most importantly, that one gauge of the partner company success is that the partner company will successfully foster community in connection with our broker-dealer, Public Ventures.
In that regard, we intend to follow a Member-focused model (further discussed below) for conducting Public Ventures-led company financings.
MDB was one of the founders of the company, provided an initial funding of $5,000,000 a subsequent funding of $758,000 and provided executive management and several board members.
A traditional perceived shortcoming of the public markets is that they attract short-sighted investors.
7 Our Partner Company Criteria We seek companies that we believe meet certain criteria.
Our criteria focuses first on the probability that an early-stage technology company ultimately can sustain its value in the public markets.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →